BRIEF-Immune Pharmaceuticals data shows that ceplene enhances response to anti PD-1 AND ANTI-PD-l1 immune checkpoint inhibitors

* New data shows that Ceplene enhances response to anti

pd-1 and anti-pd-l1 immune checkpoint inhibitors in lymphoma and

solid tumor models

Read more